Search - tctmd.com

March 12, 2026

News Daily News

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

March 03, 2026

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

February 04, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

December 18, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

December 12, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

October 24, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

Pregnancy-Related CV Complications on the Rise

Todd Neale

October 09, 2025

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

October 03, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

September 18, 2025

News Daily News

AI Tool Supports Mammograms as Method to Screen Women for CV Risk

Caitlin E. Cox

September 18, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

August 26, 2025

News Daily News

DAPT De-escalation Success Varies by Sex: Meta-analysis

August 21, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

August 06, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

August 01, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

July 31, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

July 14, 2025

News Daily News

Novel Calcium Score Accounting for Density and Location Ups MACE Prediction

July 11, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry